In:
Head & Neck, Wiley, Vol. 41, No. 1 ( 2019-01), p. 170-176
Abstract:
To evaluate and compare the diagnostic potential of 18 F‐fluorodeoxyglucose positron emission tomography/magnetic resonance imaging ( 18 FDG‐PET/MRI) and MRI for recurrence diagnostics after primary therapy in patients with adenoid cystic carcinoma (ACC). Methods A total of 32 dedicated head and neck 18 F‐FDG PET/MRI datasets were included in this analysis. MRI and 18 F‐FDG PET/MRI datasets were analyzed in separate sessions by two readers for tumor recurrence or metastases. Results Lesion‐based sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were 96%, 84%, 90%, 93%, and 91% for 18 F‐FDG PET/MRI and 77%, 94%, 95%, 73%, and 84% for MRI, resulting in a significantly higher diagnostic accuracy of 18 F‐FDG PET/MRI compared to MRI ( P 〈 .005). Conclusion 18 F‐FDG PET/MRI is superior to MRI in detecting local recurrence and metastases in patients with ACC of the head and neck. Especially concerning its negative predictive value, 18 F‐FDG PET/MRI outperforms MRI.
Type of Medium:
Online Resource
ISSN:
1043-3074
,
1097-0347
Language:
English
Publisher:
Wiley
Publication Date:
2019
detail.hit.zdb_id:
2001440-5
Permalink